Harris to hold CF drug talks with British health secretary
Health minister seeking co-ordinated approach among countries who have rejected public funding of the drug
The Minister for Health, Simon Harris, is going to hold talks with British health secretary Jeremy Hunt on the cystic fibrosis drug Orkambi this week as negotiations between the HSE and the drug’s manufacturer restart.
The HSE’s drugs committee had decided that Orkambi does not deliver enough benefit to patients to justify the €159,000 per patient, per year that its manufacturer, Vertex, has sought. But the HSE will restart negotiations with the makers...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Editorial: Our inability to agree on a model of healthcare in Ireland is unacceptable
The government is failing in its duties to provide a working healthcare system
HSE yet to cooperate with Sláintecare business case
There are concerns that the deadline for the business case, which concerns regionalisation plans, will be missed unless the HSE agrees to take part
Healthcare software developers claim they could cut waiting lists by 25%
The Irish Hospital Consultants Association has warned that the numbers waiting for either treatment or a consultation will soon increase to over one million patients
Tony O’Brien: The apparent slow collapse of Sláintecare deserves more than a shrug of the shoulders
Downplaying and media management dominated the government’s response to the resignation of Laura Magahy and Tom Keane from the Sláintecare programme